Literature DB >> 6363655

Mesangiocapillary glomerulonephritis: a long-term study of 40 cases.

C P Swainson, J S Robson, D Thomson, M K MacDonald.   

Abstract

Forty cases of mesangiocapillary glomerulonephritis are reviewed for whom both light and electron microscopy and full clinical data were available. Immunofluorescence microscopy (IF) was performed on 23 cases and complement screening (CH50, C4 and C3) on 25 cases, with follow-up period of 5-22 y. The results of EM revealed 17 cases (42 per cent.) of Type I and 23 cases (58 per cent.) of Type II MCGN but only 52 per cent. of Type II cases were correctly identified by light microscopy. Epimembranous deposits were seen as frequently in Type II as in Type I (26 per cent. and 30 per cent.) and fragmentation of glomerular capillary basement membranes (GBM) was seen in 27 per cent. of Type I cases. Overall patient survival was 49 per cent. at 10 y and that of patients who presented with nephrotic syndrome was poor (39 per cent. at 10 y). Persistent hypocomplementaemia with C3 Nephritic Factor was present in 40 per cent.; the survival of these patients was less than those with normal complement levels (70 per cent. vs 100 per cent. at 5 y) and they were also more likely to develop renal failure. Renal failure was more likely to develop in those with a creatinine clearance of less than 100 ml/min at presentation and where the biopsy showed substantial crescents in greater than 20 per cent. of glomeruli. Mean CH50, C3 and C4 was lower in the hypocomplementaemic as compared to normocomplementaemic patients, and there were no differences between Type I and Type II. IF showed immunoglobulins and fibrin as well as C3 in both Type I and Type II cases. Our results support the concept of an immune-complex mediated phase in both types of MCGN, and we further suggest that (a) epimembranous deposits are common in both Type I and Type II and (b) cases with fragmentation of the GBM should be designated Type Ia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6363655     DOI: 10.1002/path.1711410404

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).

Authors:  M A Abrera-Abeleda; C Nishimura; J L H Smith; S Sethi; J L McRae; B F Murphy; G Silvestri; C Skerka; M Józsi; P F Zipfel; G S Hageman; R J H Smith
Journal:  J Med Genet       Date:  2005-11-18       Impact factor: 6.318

2.  Glomerular basement membrane thickness in primary diffuse IgA nephropathy: ultrastructural morphometric analysis.

Authors:  M Danilewicz; M Wagrowska-Danilewicz
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 3.  Idiopathic membranoproliferative glomerulonephritis in childhood.

Authors:  C D West
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

4.  Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.

Authors:  Samih H Nasr; Anthony M Valeri; Gerald B Appel; Julius Sherwinter; Michael B Stokes; Samar M Said; Glen S Markowitz; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-29       Impact factor: 8.237

5.  Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.

Authors:  Ikechi G Okpechi; Thandiwe A L Dlamini; Maureen Duffield; Brian L Rayner; George Moturi; Charles R Swanepoel
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

6.  C3-glomerulonephritis in New Zealand - a case series.

Authors:  Luke J Sutherland; Hari Talreja
Journal:  BMC Nephrol       Date:  2020-09-17       Impact factor: 2.388

7.  Dense deposit disease in Korean children: a multicenter clinicopathologic study.

Authors:  Se Jin Park; Yong-Jin Kim; Tae-Sun Ha; Beom Jin Lim; Hyeon Joo Jeong; Yong Hoon Park; Dae Yeol Lee; Pyung Kil Kim; Kyo Sun Kim; Woo Yeong Chung; Jae Il Shin
Journal:  J Korean Med Sci       Date:  2012-10-02       Impact factor: 2.153

Review 8.  Dense deposit disease and C3 glomerulopathy.

Authors:  Thomas D Barbour; Matthew C Pickering; H Terence Cook
Journal:  Semin Nephrol       Date:  2013-11       Impact factor: 5.299

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.